T. Rowe Price Investment Management
WGS icon

T. Rowe Price Investment Management’s GeneDx Holdings WGS Stock Holding History

T. Rowe Price Investment Management’s Portfolio WGS Stock Details WGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.53M Sell
86,082
-498,068
-85% -$45.4M ﹤0.01% 560
2025
Q4 		$76M Sell
584,150
-133,853
-19% -$18.4M 0.05% 292
2025
Q3 		$77.4M Sell
718,003
-319,113
-31% -$34.8M 0.05% 311
2025
Q2 		$95.7M Buy
1,037,116
+533,383
+106% +$41.9M 0.06% 287
2025
Q1 		$44.6M Buy
+503,733
New +$43.7M 0.03% 417

Other funds holding WGS

CM
Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
ZDA
Zweig-DiMenna Associates New York $722M AUM 97.69% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

T. Rowe Price Investment Management's WGS Position: Q1 2026 in Review

T. Rowe Price Investment Management reduced its GeneDx Holdings (WGS) stake by 85% in Q1 2026, selling an estimated $45.4M and leaving 86,082 shares worth $5.53M. The position accounts for ﹤0.01% of the portfolio, ranked #560.

T. Rowe Price Investment Management first reported a position in WGS in Q1 2025 and has held it in 5 quarters since. The position peaked at $95.7M in Q2 2025. 240 funds tracked by Wall St. Rank hold WGS as of Q1 2026.

  • T. Rowe Price Investment Management held 86,082 shares of GeneDx Holdings worth $5.53M as of Q1 2026.
  • T. Rowe Price Investment Management sold 498,068 GeneDx Holdings shares in Q1 2026, an estimated $45.4M.
  • GeneDx Holdings made up ﹤0.01% of T. Rowe Price Investment Management's portfolio in Q1 2026, its #560 holding.
  • T. Rowe Price Investment Management first reported a position in GeneDx Holdings in Q1 2025 and has held it in 5 quarters since.
  • T. Rowe Price Investment Management's GeneDx Holdings position peaked at $95.7M in Q2 2025.
  • 240 funds tracked by Wall St. Rank held GeneDx Holdings as of Q1 2026.

Based on T. Rowe Price Investment Management's 13F filing for Q1 2026, filed 15 May 2026.